Tenaya Therapeutics TNYA Income Statement (2020-2026)

NASDAQ TNYA

$0.69 -0.02 (-3.13%)

As of: Aug 20, 2026 · 3:59 PM EDT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Shares Outstanding (Entity) (Quarter)																				224.23M
Revenue & cost
Revenue (Quarter)																			0.23M	1.11M
Operating items
Research & Development (Quarter)	12.94M	20.95M	24.16M	20.88M	23.76M	25.75M	25.61M	26.48M	23.09M	22.86M	25.05M	22.65M	20.35M	18.69M	21.08M	17.37M	15.36M	14.80M	14.84M	16.60M
Selling, General & Administrative (Quarter)	5.36M	5.21M	7.00M	7.74M	7.54M	8.80M	8.12M	8.63M	7.83M	8.58M	8.71M	8.17M	6.36M	5.96M	6.46M	6.71M	5.57M	5.98M	5.45M	5.41M
Operating Expenses (Quarter)																				45.20M
Other Operating Expenses (Quarter)																				23.19M
Operating Income (Quarter)																				-44.09M
EBIT (Quarter)																				-44.09M
Non-operating items
Interest & Investment Income (Quarter)																				0.70M
Other Non Operating Income (Quarter)																				-0.00M
Non Operating Income (Quarter)																				0.69M
Net income details
EBT (Quarter)																				-43.39M
Profit After Tax (Quarter)																				-43.39M
Income from Continuing Operations (Quarter)																				-43.39M
Consolidated Net Income (Quarter)																				-43.39M
Income towards Parent Company (Quarter)																				-43.39M
Net Income towards Common Stockholders (Quarter)																				-43.39M
Additional items
EPS (Basic) (Quarter)																				-0.20
EPS (Diluted) (Quarter)																				-0.20
Shares Outstanding (Quarter)																				217.57M
Shares Outstanding (Diluted) (Quarter)																				217.57M
EBITDA (Quarter)																				-44.09M
Interest Expenses (Quarter)																				4.13M